13F
中

WST WEST PHARMACEUTICAL SERVICES

2026Q1 · CUSIP 955306105 · Sector: Healthcare & Biotech

Fading · Price holds, watch
Holders
752
Δ holders QoQ
-50
Breadth percentile
Top 97%
Whale holders
284
Δ whales
-6
Inst. holding value
$17.5B
New positions
89
Closed positions
139
Price momentum (1Q)
+25.3%
Put / Call
7/9

Breadth history (34 quarters)

2018Q1: Δ-12 · h=324 2018Q2: Δ+0 · h=324 2018Q3: Δ+29 · h=353 2018Q4: Δ-1 · h=352 2019Q1: Δ+25 · h=377 2019Q2: Δ-5 · h=372 2019Q3: Δ+37 · h=409 2019Q4: Δ+37 · h=446 2020Q1: Δ+20 · h=466 2020Q2: Δ+52 · h=518 2020Q3: Δ+54 · h=572 2020Q4: Δ+17 · h=589 2021Q1: Δ-3 · h=586 2021Q2: Δ+48 · h=634 2021Q3: Δ+36 · h=670 2021Q4: Δ+61 · h=731 2022Q1: Δ-15 · h=716 2022Q2: Δ-65 · h=651 2022Q3: Δ-12 · h=639 2022Q4: Δ-1 · h=638 2023Q1: Δ+59 · h=697 2023Q2: Δ+35 · h=732 2023Q3: Δ+28 · h=760 2023Q4: Δ+25 · h=785 2024Q1: Δ-5 · h=780 2024Q2: Δ+1 · h=781 2024Q3: Δ-50 · h=731 2024Q4: Δ+13 · h=744 2025Q1: Δ-27 · h=717 2025Q2: Δ+17 · h=734 2025Q3: Δ+24 · h=758 2025Q4: Δ+44 · h=802 2026Q1: Δ-50 · h=752 2018Q1: holders=324 2018Q2: holders=324 2018Q3: holders=353 2018Q4: holders=352 2019Q1: holders=377 2019Q2: holders=372 2019Q3: holders=409 2019Q4: holders=446 2020Q1: holders=466 2020Q2: holders=518 2020Q3: holders=572 2020Q4: holders=589 2021Q1: holders=586 2021Q2: holders=634 2021Q3: holders=670 2021Q4: holders=731 2022Q1: holders=716 2022Q2: holders=651 2022Q3: holders=639 2022Q4: holders=638 2023Q1: holders=697 2023Q2: holders=732 2023Q3: holders=760 2023Q4: holders=785 2024Q1: holders=780 2024Q2: holders=781 2024Q3: holders=731 2024Q4: holders=744 2025Q1: holders=717 2025Q2: holders=734 2025Q3: holders=758 2025Q4: holders=802 2026Q1: holders=752 -65 -32.5 +0 +32.5 +65 291567843 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 16 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 12% +25.3% —
2025Q3 Top 13% -7.0% +16.6%
2025Q2 Top 18% +7.6% +2.3%
2023Q3 Top 5% +1.8% -0.3%
2023Q2 Top 5% -12.5% -11.7%
2023Q1 Top 1% +12.9% -0.5%
2021Q4 Top 7% -22.5% -15.1%
2021Q3 Top 3% -14.2% -33.5%

Options Sentiment

Put holders
7
QoQ: -2
Call holders
9
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
47.9
EPS (TTM)
$7.48
EPS YoY
+17.4%
Revenue (TTM)
$3.2B
Revenue YoY
+11.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $771M 2022-09-30: $687M 2022-12-31: $709M 2023-03-31: $717M 2023-06-30: $754M 2023-09-30: $747M 2023-12-31: $732M 2024-03-31: $695M 2024-06-30: $702M 2024-09-30: $747M 2024-12-31: $749M 2025-03-31: $698M 2025-06-30: $767M 2025-09-30: $805M 2025-12-31: $805M 2026-03-31: $845M 2022-06-30: EPS 2.48 2022-09-30: EPS 1.59 2022-12-31: EPS 1.37 2023-03-31: EPS 1.85 2023-06-30: EPS 2.06 2023-09-30: EPS 2.14 2023-12-31: EPS 1.83 2024-03-31: EPS 1.55 2024-06-30: EPS 1.51 2024-09-30: EPS 1.85 2024-12-31: EPS 1.78 2025-03-31: EPS 1.23 2025-06-30: EPS 1.82 2025-09-30: EPS 1.92 2025-12-31: EPS 1.82 2026-03-31: EPS 1.92 0M 422M 845M $M 0.00 1.36 2.73 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 43 2023-03-31: PE 47.32023-06-30: PE 57.42023-09-30: PE 46.12023-12-31: PE 45.62024-03-31: PE 46.62024-06-30: PE 42.52024-09-30: PE 46.42024-12-31: PE 322025-03-31: PE 33.92025-06-30: PE 36.82025-09-30: PE 38.72025-12-31: PE 36.92026-03-31: PE 40.5 29 45 60 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)